Guselkumab Not Linked to Worsening Liver Fibrosis in Psoriasis, 3-Year Study Finds
These findings highlight the impact of guselkumab on liver fibrosis progression among individuals living with psoriasis.
Related Articles
FDA Approves Dupilumab (Dupixent) for Chronic Spontaneous Urticaria
Dupilumab’s approval marks the first new, targeted therapy for CSU in more than a decade and is the 7th indication for a disease with underlying…
Viaskin Patch Effective in Peanut-Allergic Kids with Atopic Comorbidities
A phase 3 trial found the Viaskin peanut patch effective in desensitizing peanut-allergic children aged 1 – 3 years, regardless of asthma, atopic dermatitis, or…
Welcome Back to The Respiratory Report – 3rd Edition
In this summary, we highlight the latest issue of our pulmonology research quarterly newsletter powered by the American Lung Association Research Institute.
Study Finds Costs of Biologic Drugs for Psoriasis Rose Between 2007 to 2021
This analysis pointed to increased costs of biologics given the initiation of newer IL-17 and IL-23 inhibitors, suggesting the use of lower-cost options.
Spring Allergy Tips Clinicians Can Share with Patients, with Noah Greenspan, DPT, PT
Greenspan offers tips in treating seasonal allergies in patients with pulmonary conditions, such as long-COVID, and provides his 2025 spring allergy prediction.
Alopecia
HCPLive is a clinical news and information portal, offering physicians specialty and disease-specific resources, conference coverage, and interviews.
FDA Approves Dupilumab (Dupixent) for Chronic Spontaneous Urticaria
Dupilumab’s approval marks the first new, targeted therapy for CSU in more than a decade and is the 7th indication for a disease with underlying…
FDA Accepts Aflibercept 8 mg for Priority Review to Treat Retinal Vein Occlusion
If approved, aflibercept 8 mg would mark the first RVO treatment indicated for up to every 8-week dosing, halving the injection frequency of other anti-VEGF…
Opioid-Sparing Regimens Show Promise in Hospital Pain Management
Angel Goenawan, MD, shared findings from a meta-analysis of surgical and nonsurgical clinical trials.
